InsidersTradesSigma
Novo Nordisk A/S Stock: price and management transactions · Denmark · Finanstilsynet DK
Follow the Novo Nordisk A/S share price and the full insider trade history of the company, a publicly traded company based in Denmark. Shares are quoted on DK DK, under the oversight of Finanstilsynet DK. Operating in the Health Care sector, Novo Nordisk A/S has logged 206 reports. The latest transaction was reported on 12 May 2026 (Gift). Among the most active insiders: member/Executive/Associated Person. The full history is accessible without an account.
206
Insider Decl.
0
Thresholds
€4m
39 ops.
Buy Volume
€6bn
56 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 12 May 2026
Declarations206 total
●
Munk Knudsen, Executive Vice President,Executives
50 shares@ DKK 294.2670.0% of flowShareOutside a trading venueDK:1441704
26,246 shares@ DKK 315.600.0% of flowShareJANE STREET NETHERLANDS B.V.DK:1419574
22,000 shares@ DKK 319.800.0% of flowShareNasdaq CopenhagenDK:1419156
1,085 shares0ShareOutside a trading venueDK:1418330
6,450 shares@ DKK 312.500.0% of flowShareNasdaq CopenhagenDK:1401014
Ideal exit: 14 Aug 2026 (T+270)
18,634 shares0ShareOutside a trading venueDK:1399962
952 shares@ DKK 349.060.0% of flowShareNew York Stock ExchangeDK:1384043
Ideal exit: 15 May 2026 (T+270)
12,000 shares@ DKK 326.000.0% of flowShareNasdaq CopenhagenDK:1382865
28,710 shares@ DKK 295.000.0% of flowShareNasdaq CopenhagenDK:1382513
74 shares@ DKK 316.750.0% of flowShareCGETDK:1382344
20,000 shares@ DKK 444.820.0% of flowShareNasdaq CopenhagenDK:1362269
40,000 shares@ DKK 620.260.1% of flowShareNasdaq CopenhagenDK:1341672
1,407 shares0ShareOutside a trading venueDK:1341302
2,500 shares@ DKK 709.250.0% of flowShareNew York Stock ExchangeDK:1328724
Ideal exit: 15 Aug 2025 (T+270)
1,300 shares@ DKK 743.310.0% of flowShareNew York Stock ExchangeDK:1327620
Ideal exit: 9 Aug 2025 (T+270)
18,634 shares0ShareOutside a trading venueDK:1327424
1,400 shares@ DKK 753.020.0% of flowShareNew York Stock ExchangeDK:1326827
Ideal exit: 3 Aug 2025 (T+270)
1,400 shares@ DKK 697.240.0% of flowShareNew York Stock ExchangeDK:1326582
Ideal exit: 3 Aug 2025 (T+270)
12.742 shares@ DKK 904.410.0% of flowShareNew York Stock ExchangeDK:1313875
Ideal exit: 25 May 2025 (T+270)
@ €122.3383ShareNew York Stock ExchangeDK:1311855
Ideal exit: 17 May 2025 (T+270)
8,480 shares@ DKK 895.500.0% of flowShareNasdaq CopenhagenDK:1310732
11 shares@ DKK 891.200.0% of flowShareNasdaq CopenhagenDK:1310299
Ideal exit: 6 May 2025 (T+270)
208.385 shares@ DKK 819.720.0% of flowShareNew York Stock ExchangeDK:1310156
Ideal exit: 4 May 2025 (T+270)
37 shares@ DKK 8.000.0% of flowShareNew York Stock ExchangeDK:1309977
Ideal exit: 5 May 2025 (T+270)
25 of 206 declarations
About Novo Nordisk A/S
Novo Nordisk A/S is a Danish pharmaceutical company specializing in the treatment of diabetes and other chronic diseases. It is listed on the Copenhagen Stock Exchange under the symbol NOVO.
